Logo

Ingenium Acquires Two Patents from Incyte

May 12, 2004

NEW YORK, May 12 (GenomeWeb News) - Ingenium Pharmaceuticals has acquired two patents relating to generating rodent models from Incyte, the company said today.

 

The patents, US patent No. 5,994,075 and US patent No. 6,015,670, enable Ingenium to provide mouse and rat models developed using its Ingenotyping technology to partners in the US. Previously, Munich-based Ingenium held a license to the patents.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.